Literature DB >> 10418740

Lipid peroxidation and antioxidant defenses in cystic fibrosis patients.

H Benabdeslam1, H Abidi, I Garcia, G Bellon, R Gilly, A Revol.   

Abstract

Lipid peroxidation biomarkers and antioxidant status were measured in 76 cystic fibrosis (CF) patients and compared to 40 control subjects. Univariate and multivariate statistics were performed in this study. Results showed that indicators of lipid peroxidation were higher in CF patients than in controls; thiobarbituric acid reactants and autoantibodies against oxidized low-density lipoproteins were significantly increased in CF patients. Red blood cells and whole blood glutathione peroxidase activities were lower in CF patients than in controls. No difference in red blood cell superoxide dismutase activity was observed. Measured concentration of glutathione peroxidase in plasma showed a higher mean value of this protein in CF patients than in controls. Retinol, alpha-tocopherol and beta-carotene concentrations were all reduced in CF patients as compared to controls; this was particularly pronounced for beta-carotene. The decreased alpha-tocopherol concentration was associated with higher percent hemolysis in CF patients. The results of this study indicate that both lipid peroxidation biomarkers and antioxidant status were disturbed in CF patients, despite medical assistance. Measures of oxidative stress parameters, such as thiobarbituric acid reactants, glutathione peroxidase, and beta-carotene concentrations can be considered as significant indicators to discriminate CF patients and control subjects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10418740     DOI: 10.1515/CCLM.1999.082

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  10 in total

Review 1.  The role of vitamins in cystic fibrosis.

Authors:  S B Carr; J McBratney
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

Review 2.  Vitamins C and E: beneficial effects from a mechanistic perspective.

Authors:  Maret G Traber; Jan F Stevens
Journal:  Free Radic Biol Med       Date:  2011-05-25       Impact factor: 7.376

3.  Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003.

Authors:  André M Cantin; Terry B White; Carroll E Cross; Henry Jay Forman; Ronald J Sokol; Drucy Borowitz
Journal:  Free Radic Biol Med       Date:  2006-09-29       Impact factor: 7.376

4.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

5.  Serotonin is a key factor for mouse red blood cell survival.

Authors:  Pascal Amireault; Elisa Bayard; Jean-Marie Launay; David Sibon; Caroline Le Van Kim; Yves Colin; Michel Dy; Olivier Hermine; Francine Côté
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

6.  Protective effect of Baccharis trimera extract on acute hepatic injury in a model of inflammation induced by acetaminophen.

Authors:  Bruno da Cruz Pádua; Joamyr Victor Rossoni Júnior; Cíntia Lopes de Brito Magalhães; Míriam Martins Chaves; Marcelo Eustáquio Silva; Maria Lucia Pedrosa; Gustavo Henrique Bianco de Souza; Geraldo Célio Brandão; Ivanildes Vasconcelos Rodrigues; Wanderson Geraldo Lima; Daniela Caldeira Costa
Journal:  Mediators Inflamm       Date:  2014-11-12       Impact factor: 4.711

7.  Increased susceptibility of cystic fibrosis airway epithelial cells to ferroptosis.

Authors:  Pramila Maniam; Ama-Tawiah Essilfie; Murugan Kalimutho; Dora Ling; David M Frazer; Simon Phipps; Gregory J Anderson; David W Reid
Journal:  Biol Res       Date:  2021-12-13       Impact factor: 5.612

8.  Preliminary evidence for cell membrane amelioration in children with cystic fibrosis by 5-MTHF and vitamin B12 supplementation: a single arm trial.

Authors:  Cinzia Scambi; Lucia De Franceschi; Patrizia Guarini; Fabio Poli; Angela Siciliano; Patrizia Pattini; Andrea Biondani; Valentina La Verde; Oscar Bortolami; Francesco Turrini; Franco Carta; Ciro D'Orazio; Baroukh M Assael; Giovanni Faccini; Lisa M Bambara
Journal:  PLoS One       Date:  2009-03-11       Impact factor: 3.240

9.  Profiling the proteome of exhaled breath condensate in healthy smokers and COPD patients by LC-MS/MS.

Authors:  Marco Fumagalli; Fabio Ferrari; Maurizio Luisetti; Jan Stolk; Pieter S Hiemstra; Daniela Capuano; Simona Viglio; Laura Fregonese; Isa Cerveri; Federica Corana; Carmine Tinelli; Paolo Iadarola
Journal:  Int J Mol Sci       Date:  2012-10-29       Impact factor: 5.923

Review 10.  Antioxidant supplementation for lung disease in cystic fibrosis.

Authors:  Oana Ciofu; Sherie Smith; Jens Lykkesfeldt
Journal:  Cochrane Database Syst Rev       Date:  2019-10-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.